Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: An experimental study

References

• Schubert GA, Thome C. Cerebral blood flow changes in acute subarachnoid hemorrhage. Frontiers in Bioscience 2008; 13: 1594–1603
   PubMedGoogle Scholar
• Javadpour M. Cerebral vasospasm: New strategies in research and treatment. (Acta Neurochirurgica Supplement 104) British Journal of Neurosurgery 2009; 23: 566
   Google Scholar
• Kocaogullar Y, Ilik K, Esen H, et al. Preventive effects of intraperitoneal selenium on cerebral vasospasm: In experimental subarachnoid hemorrhage. Journal of Neurosurgery and Anesthesiology 2009; 23, [Epub ahead of print]
   Google Scholar
• Güney O, Erdi F, Esen H, et al. N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. Surgical Neurology 2009; 6, [Epub ahead of print]
   Google Scholar
• Feeney DM, Boyeson MG, Linn RT, et al. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Research 1981; 211: 67–77
   PubMed Web of Science ®Google Scholar
• Himori N, Watanabe H, Akaike N, et al. Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability. Journal of Pharmocology Methods 1990; 23: 311–327
   PubMedGoogle Scholar
• Pyne-Geithman GJ, Caudell DN, Prakash P, et al. Glutathione peroxidase and subarachnoid hemorrhage: Implications for the role of oxidative stress in cerebral vasospasm. Neurological Research 2009; 3: 195–199
   Google Scholar
• Naziroğlu M, Kutluhan S, Yilmaz M. Selenium and topiramate modulates brain microsomal oxidative stress values, Ca2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats. Journal of Membrane Biology 2008; 225: 39–49
   PubMed Web of Science ®Google Scholar
• Ste-Marie L, Vachon P, Vachon L, et al. Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. Canadian Journal of Neurological Science 2000; 27: 152–159
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yuki S, Egawa M, et al. Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. Journal of Pharmacology and Experimental Therapy 1994; 268: 1597–1604
   PubMed Web of Science ®Google Scholar
• Belen D, Besalti O, Yiğitkanli K, et al. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage. Acta Neurochirgica (Wien) 2007; 149: 1041–1048
   PubMedGoogle Scholar
• Espinosa F, Weir B, Shnitka T. Electron microscopy simian cerebral arteries after subarachnoid haemorhage and after the injection of horseradish peroxidase. Neurosurgery 1986; 19: 935–945
   PubMed Web of Science ®Google Scholar
• Atalay B, Bolay H, Dalkara T, et al. Transcorneal stimulation of trigeminal nevre afferents to increase cerebral flow in rats with cerebral vasospasm: A non-invasive method to activate the trigeminovascular reflex. Journal of Neurosurgery 2002; 97: 1179–1183
   PubMedGoogle Scholar
• Atalay B, Caner H, Cekinmez M, et al. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2006; 59: 1102–1108
   PubMed Web of Science ®Google Scholar
• Handa Y, Kubota T, Kaneko M, et al. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochirgica (Wien) 1995; 132: 92–97
   PubMed Web of Science ®Google Scholar
• Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurismal subarachnoid hemorrhage: Putative mechanisms and novel approaches. Journal of Neuroscience Research 2009; 87: 1–11
   PubMed Web of Science ®Google Scholar
• Takasago T, Peters EE, Graham DI, et al. Neuroprotective efficacy of ebselen, an antioxidant with anti- infammatory actions, in a rodent model of permanent middle cerebral artery occlusion. British Journal of Pharmacology 1997; 122: 1251–1256
   PubMed Web of Science ®Google Scholar
• Miles AN, Knuckey NW. Apoptotic neuronal death following cerebral ischaemia. Journal of Clinical Neuroscience 1998; 5: 125–145
   PubMedGoogle Scholar
• Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462
   PubMed Web of Science ®Google Scholar
• Choi DW. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends in Neuroscience 1995; 18: 58–60
   PubMed Web of Science ®Google Scholar
• Choi DW. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends in Neuroscience 1988; 11: 465–469
   PubMed Web of Science ®Google Scholar
• Yakut N, Yasa H, Bahriye Lafci B, et al. The influence of levosimendan and iloprost on renal ischemia-reperfusion: An experimental study. Interactions in Cardiovascular Thoracic Surgery 2008; 7: 235–239
   PubMedGoogle Scholar
• Lilleberg J, Sundberg S, Häyhä M, et al. Haemodynamic dose efficacy of levosimendan in healthy volunteers. European Journal of Clinical Pharmacology 1994; 47: 267–274
   PubMed Web of Science ®Google Scholar
• Jamali IN, Kersten JR, Pagel PS, et al. Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesthesia & Analgesia 1997; 85: 23–29
   PubMed Web of Science ®Google Scholar
• Katircioglu SF, Seren M, Parlar AI, et al. Levosimendan effect on spinal cord ischemia reperfusion injury following aortic clamping. Journal of Cardiac Surgery 2008; 23: 44–48
   PubMed Web of Science ®Google Scholar
• Lafci B, Yasa H, Ilhan G, et al. Protection of the spinal cord from ischemia: Comparative effects of levosimendan and iloprost. European Surgery Review 2008; 41: 1–7
   PubMedGoogle Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid rection. Analytical Biochemistry 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Doczi TP. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2001; 32: 81–87
   Google Scholar
• Parissis J, Adamopoulos S, Antoniades C, et al. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. American Journal of Cardiology 2004; 93: 1309–1312
   PubMed Web of Science ®Google Scholar
• Bavbek M, Kilinc K, Durieux M, et al. Systemic administration of mexiletine for attenuation of cerebral vasospasm following experimental subarachnoid haemorrhage. Caner H, Kwan AL. Acta Neurochirgica (Wien) 2000; 142: 455–461
   PubMedGoogle Scholar
• Chopp M, Li Y. Apoptosis in focal cerebral ischemia. Acta Neurochirgica Supplementum (Wien) 1996; 66: 21–26
   PubMedGoogle Scholar
• Li Y, Chopp M, Jiang N, Zhang ZG, Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 1995; 26: 1252–1257
   PubMed Web of Science ®Google Scholar
• Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes. American Journal of Cardiology 2005; 96: 26–31
   PubMed Web of Science ®Google Scholar
• Parissis JT, Andreadou I, Bistola V, et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart. Expert Opinions in Investigative Drugs 2008; 17: 1143–1150
   PubMed Web of Science ®Google Scholar
• Jahromi BS, Aihara Y, Ai J, et al. Voltage-gated K+ channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage. Journal of Cerebral Blood Flow Metabolism 2008; 28: 797–811
   PubMedGoogle Scholar
• Jahromi BS, Aihara Y, Ai J, et al. Temporal profile of potassium channel dysfunction incerebrovascular smooth muscle after experimental subarachnoid haemorrhage. Neuroscience Letters 2008; 25: 81–86
   Google Scholar
• Takahashi R, Endoh M. Dual regulation of myofilament Ca2+ sensitivity by levosimendanin normal and acidotic conditions in aequorin-loaded canine ventricular myocardium. British Journal of Pharmacology 2005; 145: 1143–1152
   PubMed Web of Science ®Google Scholar
• Pataricza J, Szolnoky J, Krassoi I, et al. Vasorelaxing effect of levosimendan against 5-hydroxytryptamine-induced contractions in isolated human conduit bypass grafts. Journal of Pharmacy and Pharmacology 2006; 58: 1107–1112
   PubMed Web of Science ®Google Scholar
• Yokoshiki H, Katsube Y, Sunagawa M, et al. The novel calcium sensitizer levosimendanactivates the ATP-sensitive K+ channel in rat ventricular cells. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 375–383
   PubMed Web of Science ®Google Scholar
• Goto Y, Katsuya H, Takasago T, et al. Calcium-sensitising drug reduces energy cost for excitation-contraction coupling in the failing heart, but not in the normal heart. Circulation 1996; 94: 1545
   PubMedGoogle Scholar
• Harkin CP, Pagel PS, Tessmer JP, et al. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. Journal of Cardiovascular Pharmacology 1995; 26: 179–288
   PubMedGoogle Scholar
• Edes I, Kiss E, Kitada Y, et al. Effects of levosimendan, a cardiotonic agent targeted totroponin C, on cardiac function and on phosphorylation and Ca sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circulation Research 1995; 77: 107–113
   PubMed Web of Science ®Google Scholar
• Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesthesia & Analgesia 2000; 90: 5–11
   PubMed Web of Science ®Google Scholar